SCHEMBL1720325

SCHEMBL1720325

CCCn1c(-c2ccc(NCc3cccc(C(F)(F)F)c3)nc2)nc2[nH]c(=O)[nH]c(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.42
ADORA2A P29274 5/20 0.42
ADORA2B P29275 5/20 0.42
SCD O00767 6/20 0.41
ADORA1 P30542 5/20 0.41
GRIN1 Q05586 4/20 0.40
GRIN2B Q13224 4/20 0.40
EGFR P00533 1/20 0.39
PLK4 O00444 1/20 0.39
CDK2 P24941 1/20 0.39
IRAK1 P51617 1/20 0.39
RPS6KA3 P51812 1/20 0.39
PLK3 Q9H4B4 1/20 0.39
CSNK1G3 Q9Y6M4 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2686174 0.78 ADORA2B (0.66) ADORA3ADORA2AADORA2BADORA1
SCHEMBL2687202 0.78 ADORA2B (0.51) ADORA3ADORA2AADORA2BADORA1PLK4
SCHEMBL1720374 0.77 STIM1 (0.43) ADORA3ADORA2AADORA2BADORA1KDM4E
SCHEMBL4016921 0.76 ADORA2B (0.41) ADORA3ADORA2AADORA2BADORA1PLK4
SCHEMBL1727143 0.75 ADORA2B (0.41) ADORA3ADORA2AADORA2BSCDADORA1
SCHEMBL1720580 0.74 SCD (0.38) ADORA3ADORA2AADORA2BSCDADORA1
SCHEMBL1724494 0.74 ADORA2B (0.46) ADORA3ADORA2AADORA2BSCDADORA1
SCHEMBL1720327 0.72 EGFR (0.38) ADORA3ADORA2AADORA2BSCDEGFR
SCHEMBL15642798 0.71 ADORA1 (0.40) ADORA3ADORA2AADORA2BADORA1GRIN1
SCHEMBL4019325 0.68 LMNA (0.42) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed